(Q46630310)
Statements
1 reference
Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group Study (English)
1 reference
Russell J Schilder
1 reference
Michael W Sill
1 reference
Xiaowei Chen
1 reference
Kathleen M Darcy
1 reference
Steven L Decesare
1 reference
George Lewandowski
1 reference
Roger B Lee
1 reference
Cletus A Arciero
1 reference
Hong Wu
1 reference
Andrew K Godwin
1 reference
1 August 2005
1 reference
1 reference
11
1 reference
5539-5548
1 reference
15
1 reference
Identifiers
1 reference
1 reference